| Autor: |
Carmel M McVicar, Liza M Colhoun, Jodie L Abrahams, Claire L Kitson, Ross Hamilton, Reinhold J Medina, Dash Durga, Tom A Gardiner, Pauline M Rudd, Alan W Stitt |
| Jazyk: |
angličtina |
| Rok vydání: |
2010 |
| Předmět: |
|
| Zdroj: |
PLoS ONE, Vol 5, Iss 7, p e11870 (2010) |
| Druh dokumentu: |
article |
| ISSN: |
1932-6203 |
| DOI: |
10.1371/journal.pone.0011870 |
| Popis: |
BackgroundErythropoiesis stimulating agents (ESAs) are widely used to treat anaemia but concerns exist about their potential to promote pathological angiogenesis in some clinical scenarios. In the current study we have assessed the angiogenic potential of three ESAs; epoetin delta, darbepoetin alfa and epoetin beta using in vitro and in vivo models.Methodology/principal findingsThe epoetins induced angiogenesis in human microvascular endothelial cells at high doses, although darbepoetin alfa was pro-angiogenic at low-doses (1-20 IU/ml). ESA-induced angiogenesis was VEGF-mediated. In a mouse model of ischaemia-induced retinopathy, all ESAs induced generation of reticulocytes but only epoetin beta exacerbated pathological (pre-retinal) neovascularisation in comparison to controls (pConclusionsThis study has implications for treatment of patients as there are clear differences in the angiogenic potential of the different ESAs. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
